IDXX:NASDAQ
IDEXX Laboratories Inc
$518,00
arrow_upward
+0,95%(+4,86) 1G
$518,00
0,00% (0,00)
bedtimeKapanış sonrası
Kapandı: 9 Eki, 16:00:01 GMT-4 · USD
search
Tüm semboller
| Sembol | Fiyat | Değişiklik | Değişiklik % |
|---|
insights_autoIDXX ile ilgili en önemli analizler oluşturuluyor...
Açık
$513,67
Yüksek
$522,02
Düşük
$513,10
Piy. değ.
40,81 Mr
Ort. hacim
505,84 B
İşlem Hacmi
466,78 B
F/K oranı
36,41
52 haftalık en yüksek
$769,98
52 haftalık en düşük
$500,61
HBK
$14,23
Beta
1,55
Tedavüldeki hisse senedi sayısı
78,78 Mn
Çalışan sayısı
11 B
Açık
$513,67
Yüksek
$522,02
Düşük
$513,10
Piy. değ.
40,81 Mr
Ort. hacim
505,84 B
İşlem Hacmi
466,78 B
F/K oranı
36,41
52 haftalık en yüksek
$769,98
52 haftalık en düşük
$500,61
HBK
$14,23
Beta
1,55
Tedavüldeki hisse senedi sayısı
78,78 Mn
Çalışan sayısı
11 B
Haberler
Web kaynaklarından ve haber iş ortaklarından
StreetInsider
·
1 saat önce
XRP News Today: Nasdaq Exposure Could Transform XRP as Remittix Targets Everyday Payment Adoption
Mitrade
·
48 dakika önce
XRP’s Nasdaq Moment Nears: 5 Things to Know About Evernorth
Barchart.com
·
4 saat önce
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Seeking Alpha
·
6 saat önce
S&P 500: The Quick And Easy Days Are Over (SP500)
Profil
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
IDEXX Laboratories Inc hakkında
CEOJay Mazelsky
Çalışan Sayısı11 B
Kuruluş Tarihi19 Ara 1983
Genel MerkezWestbrook, Maine, Amerika Birleşik Devletleri
Sektör-
Web Sitesiidexx.com